VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

MDS 2021 | Integrated approaches to the diagnosis of MDS & MPNs

Anne Tierens, MD, PhD, Princess Margaret Cancer Centre, Toronto, Canada, discusses the integrated approaches used for the diagnosis of myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs), and how this impacts treatment decisions. Antigen expression profiles and molecular genetics have been extremely valuable when diagnosing different phases of the disease and flow cytometry is helpful in identifying the expression of monocytes from clonal processes. This interview took place at the 16th International Congress on Myelodysplastic Syndromes, held virtually in 2021.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter